KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universal Health Services (UHS) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Universal Health Services (UHS) over the last 17 years, with Q3 2025 value amounting to -$269.4 million.

  • Universal Health Services' Cash from Investing Activities fell 142.15% to -$269.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 1196.24%. This contributed to the annual value of -$911.1 million for FY2024, which is 1936.84% down from last year.
  • Universal Health Services' Cash from Investing Activities amounted to -$269.4 million in Q3 2025, which was down 142.15% from -$305.9 million recorded in Q2 2025.
  • Universal Health Services' 5-year Cash from Investing Activities high stood at -$73.3 million for Q3 2022, and its period low was -$305.9 million during Q2 2025.
  • Its 5-year average for Cash from Investing Activities is -$214.9 million, with a median of -$221.4 million in 2021.
  • As far as peak fluctuations go, Universal Health Services' Cash from Investing Activities surged by 5833.96% in 2022, and later plummeted by 14059.54% in 2023.
  • Over the past 5 years, Universal Health Services' Cash from Investing Activities (Quarter) stood at -$254.8 million in 2021, then grew by 2.5% to -$248.4 million in 2022, then rose by 3.84% to -$238.8 million in 2023, then grew by 12.92% to -$208.0 million in 2024, then fell by 29.53% to -$269.4 million in 2025.
  • Its Cash from Investing Activities was -$269.4 million in Q3 2025, compared to -$305.9 million in Q2 2025 and -$271.3 million in Q1 2025.